Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy

Author： Ghavamian R.   Blute M.L.   Bergstralh E.J.   Slezak J.   Zincke H.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.54, Iss.1, 1999-07, pp. : 105-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy

By Cookson M.S.   Fleshner N.E.   Soloway S.M.   Fair W.R.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 887-893

Elsevier

Access to resources Recommend Favorite

Early prostate-specific antigen failure following radical perineal versus retropubic prostatectomy: the importance of seminal vesicle excision

By Theodorescu D.   Lippert M.C.   Broder S.R.   Boyd J.C.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 277-282

Elsevier

Access to resources Recommend Favorite

Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical radical prostatectomy

By Coetzee L.J.   Hars V.   Paulson D.F.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 232-235

Elsevier

Access to resources Recommend Favorite

Management of patients with rising prostate-specific antigen after radical prostatectomy

By Laufer M.   Pound C.R.   Carducci M.A.   Eisenberger M.A.  

Urology, Vol. 55, Iss. 3, 2000-03 ,pp. : 309-315

Elsevier

Access to resources Recommend Favorite

Anterior distribution of Stage T1c nonpalpable tumors in radical prostatectomy specimens

By Takashima R.   Egawa S.   Kuwao S.   Baba S.  

Urology, Vol. 59, Iss. 5, 2002-05 ,pp. : 692-697

Elsevier

Access to resources Recommend Favorite